BILL ANALYSIS
S860
NEUTRALBUST FENTANYL Act
S860 (BUST FENTANYL Act) has been assessed with a neutral outlook for investors. This legislation directly affects CACI International ($CACI), Palantir ($PLTR) and Science Applications International ($SAIC). The primary sectors impacted are Defense and Technology. View the full bill text on Congress.gov.
neutral
Market Sentiment
3
Affected Stocks
2
Sectors Impacted
Key Takeaways for Investors
BUST FENTANYL Act mandates new intelligence reports on fentanyl trafficking but authorizes zero new funding, capping near-term contractor revenue impact.
Primary beneficiaries are data analytics and intelligence support contractors $PLTR, $CACI, and $SAIC, but only through existing contract vehicles.
All three stocks are in a 30-day downtrend ($PLTR -5.99%, $CACI -6.31%, SAIC +0.46%), reflecting broader sector weakness rather than legislative catalysts.
How S860 Affects the Market
The BUST FENTANYL Act provides mild structural support for government IT and intelligence contractors, but the zero-funding authorization means the bill will not independently drive revenue growth. $PLTR at $137.53 has the most direct exposure through its Gotham platform, but the 30-day decline of 5.99% indicates the market is not pricing in any new contract catalysts from this legislation. $CACI at $509.56 and $SAIC at $95.36 similarly show no positive price reaction to the bill's April 28 calendar placement. Investors should view this bill as neutral — it confirms existing contract demand but does not create new funded programs. The higher-impact legislation for these contractors remains the annual defense appropriations bills.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | S860 |
| Market Sentiment | neutral |
| Event Date | |
| Affected Sectors | Defense, Technology |
| Affected Stocks | CACI International ($CACI), Palantir ($PLTR), Science Applications International ($SAIC) |
| Source | View on Congress.gov → |
Summary
The BUST FENTANYL Act (S860) is a procedural bill that mandates new intelligence reports on fentanyl trafficking but authorizes zero new funding. The bill provides mild tailwinds for government contractors like $PLTR, $CACI, and $SAIC through existing contract vehicles, but near-term revenue impact is capped by the lack of appropriations. All three stocks have declined 4-6% in the past 30 days, reflecting broader sector weakness rather than legislative catalysts.
Full AI Market Analysis
Stocks Affected by S860
Sectors Impacted by S860
Related Defense Legislation
Understand the Terms
Free — no credit card
Know which stocks S860 moves — before the market does
HillSignal scores every bill, federal contract, and insider filing for market impact and emails you the high-conviction ones. Free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →